A Multicenter, Randomized, Controlled Trial Comparing Surfaxin (Lucinactant) Lavage With Standard Care for Treatment of Meconium Aspiration Syndrome

2002202 citationsJournal Article

Authors

Thomas E. Wiswell · Thomas Jefferson University

G. R. Knight · Thomas Jefferson University

Neil N. Finer · University of California, San Diego

Steven M. Donn · Michigan Medicine

Hemant Desai · Thomas Jefferson University

William F. Walsh · Vanderbilt University Medical Center

Krishnamurthy Sekar

Abstract

Dilute Surfaxin lavage seems to be a safe and potentially effective therapy in the treatment of MAS. Data from this investigation support future prospective, controlled clinical trials of bronchoalveolar lavage with Surfaxin in neonates with MAS.

Topics & Keywords

Neonatal Respiratory Health Research Neuroscience of respiration and sleep Respiratory Support and Mechanisms

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PEDIATRICS

Volume 109, Issue 6, pp. 1081-1087

DOI: 10.1542/peds.109.6.1081

Field-Weighted Citation Impact: 13.49